THERMO FISHER SCIENTIFIC INC.
Company Stats
- Market Cap
- $249.6B
- as of Sep 30, 2026
- Enterprise Value
- $279.2B
- Shares Outstanding
- 370.5M
- Free Float
- 99.9%
Income Statement
- Revenue
- $44.6B
- Operating Income
- $7.7B
- Net Income
- $6.7B
- EBITDA
- $8.8B
- Non-cash Impairment
- $94.0M
- Revenue Growth, 3Y
- -0.3%
- FCF Margin, 3Y Avg
- 15.7%
- FCF Margin, Worst Year
- 14.1%
Cash Flow
- Free Cash Flow
- $6.3B
- FCF Yield
- 2.5%
- Owner FCF Yield
- 2.4%
Balance Sheet
- Cash & Equivalents
- $9.9B
- Total Debt
- $39.5B
- Net Debt
- $29.6B
- Net Debt / EBITDA
- 3.37x
- EV / EBITDA
- 31.74x
- Net Debt / EBIT
- 3.82x
Returns & Capital
- Dividends Paid
- $636.0M
- Dividend Yield
- 0.3%
- Dividend Payout, 3Y Avg
- 9.1%
- Share Repurchases
- $3.0B
- Buyback Yield, 3Y Avg
- 1.3%
- SBC, 3Y Avg
- $296.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $44.6B | $6.3B | 14.1% |
| FY2024 | $42.9B | $7.3B | 16.9% |
| FY2023 | $42.9B | $6.9B | 16.2% |
| FY2022 | $44.9B | $6.9B | 15.4% |
| FY2021 | $39.2B | $6.8B | 17.3% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 7, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back